Literature DB >> 9873828

Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells.

S H Kim1, G S Yeo, Y S Lim, C D Kang, C M Kim, B S Chung.   

Abstract

MDR1 promoter has been shown to contain heat shock elements (HSE), and it has been reported that FM3A/M and P388/M MDR cells show a constitutively activated heat shock factor (HSF), suggesting that HSF might be an important target for reversing the multidrug resistance. Therefore, it was examined whether quercetin, which has been shown to interfere with the formation of the complex between HSE and HSF, and to downregulate the level of HSF1, can sensitize MDR cells against anticancer drugs by inhibition of HSF DNA-binding activity. In this study, quercetin appeared to inhibit the constitutive HSF DNA-binding activity and the sodium arsenite-induced HSF DNA-binding activity in the MDR cells. The basal and sodium arsenite-induced MDRCAT activities were remarkably suppressed by the treatment of quercetin. These results were well consistent with the finding that the treatment of quercetin decreased the expression level of P-gp, MDR1 gene product, in dose-dependent manner, and markedly increased the sensitivity of MDR cells to vincristine or vinblastine. These results suggest that quercetin can decrease the expression of P-gp via inhibition of HSF DNA-binding activity, and might be useful as a chemosensitizer in MDR cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873828     DOI: 10.1038/emm.1998.13

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  21 in total

1.  A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma.

Authors:  A T Hoang; J Huang; N Rudra-Ganguly; J Zheng; W C Powell; S K Rabindran; C Wu; P Roy-Burman
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.

Authors:  Feng Lv; Yang Yu; Bin Zhang; Dong Liang; Zhao-Ming Li; Wei You
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

3.  Expression of mdr49 and mdr65 multidrug resistance genes in larval tissues of Drosophila melanogaster under normal and stress conditions.

Authors:  Madhu G Tapadia; S C Lakhotia
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

4.  PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy.

Authors:  Smita Pimple; Arehalli S Manjappa; Mukesh Ukawala; R S R Murthy
Journal:  Cancer Nanotechnol       Date:  2012-05-09

5.  Heat shock-independent induction of multidrug resistance by heat shock factor 1.

Authors:  Thierry Tchénio; Marilyne Havard; Luis A Martinez; François Dautry
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 6.  The complex relationship between multiple drug resistance and the tumor pH gradient: a review.

Authors:  Tomas Koltai
Journal:  Cancer Drug Resist       Date:  2022-04-03

7.  Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines.

Authors:  Stella Chai; Kenneth Kw To; Ge Lin
Journal:  Chin Med       Date:  2010-07-25       Impact factor: 5.455

8.  Contrasting cellular stress responses of Baikalian and Palearctic amphipods upon exposure to humic substances: environmental implications.

Authors:  Marina V Protopopova; Vasiliy V Pavlichenko; Ralph Menzel; Anke Putschew; Till Luckenbach; Christian E W Steinberg
Journal:  Environ Sci Pollut Res Int       Date:  2014-07-23       Impact factor: 4.223

9.  Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.

Authors:  Kyoung-Ah Kim; Pil-Whan Park; Ji-Young Park
Journal:  Eur J Clin Pharmacol       Date:  2009-02-17       Impact factor: 2.953

Review 10.  A new dawn for the use of traditional Chinese medicine in cancer therapy.

Authors:  Harendra S Parekh; Gang Liu; Ming Q Wei
Journal:  Mol Cancer       Date:  2009-03-20       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.